Efficacy and Safety of TV-1380 for Facilitation of Abstinence in Cocaine-Dependent Subjects

Study Title
Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects
Teva Identifier
TV1380-COA-201
ClinicalTrials.gov Identifier
NCT01887366
Study Status
Completed
Trial Condition(s)
Cocaine Addiction
Interventions
Drug: TV-1380 150 mg | Drug: TV-1380 300 mg | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial



Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 60 Years
Trial Duration
06/01/2013 - 10/01/2014
Phase
Phase 2

Study Type

Interventional